INTERVIEW: KDDF CEO On Building R&D Success, Pipelines
This article was originally published in PharmAsia News
The South Korean pharma industry and government are notching up efforts to pursue open innovation for successful R&D, and the state-run Korea Drug Development Fund (KDDF) is at the center of this push. The CEO of the fund, which is supported by multiple government ministries, talks to PharmAsia News about how it is supporting domestic firms to more successfully acquire and develop novel global drugs.
Register for our free email digests: